GPR21
gene geneOn this page
Summary
GPR21 (G protein-coupled receptor 21, HGNC:4476) is a protein-coding gene on chromosome 9q33.2, encoding Probable G-protein coupled receptor 21 (Q99679). Orphan receptor.
This gene encodes a member of the G-protein-coupled receptor 1 family. G-protein coupled receptors are membrane proteins which activate signaling cascades as a response to extracellular stress. The encoded protein activates a Gq signal transduction pathway which mobilizes calcium.
Source: NCBI Gene 2844 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 48 total
- Druggable target: yes
- MANE Select transcript:
NM_005294
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4476 |
| Approved symbol | GPR21 |
| Name | G protein-coupled receptor 21 |
| Location | 9q33.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000188394 |
| Ensembl biotype | protein_coding |
| OMIM | 601909 |
| Entrez | 2844 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000616002
RefSeq mRNA: 1 — MANE Select: NM_005294
NM_005294
CCDS: CCDS6849
Canonical transcript exons
ENST00000616002 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003728523 | 123033667 | 123033742 |
| ENSE00003732022 | 123034171 | 123035665 |
Expression profiles
Bgee: expression breadth ubiquitous, 138 present calls, max score 85.29.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1208 / max 215.3042, expressed in 285 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 98435 | 2.1208 | 285 |
Top tissues by expression
274 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| diaphragm | UBERON:0001103 | 85.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.25 | gold quality |
| cortical plate | UBERON:0005343 | 82.98 | gold quality |
| type B pancreatic cell | CL:0000169 | 81.29 | gold quality |
| olfactory bulb | UBERON:0002264 | 81.26 | gold quality |
| right coronary artery | UBERON:0001625 | 78.95 | gold quality |
| popliteal artery | UBERON:0002250 | 75.59 | gold quality |
| tibial artery | UBERON:0007610 | 75.56 | gold quality |
| left coronary artery | UBERON:0001626 | 75.35 | gold quality |
| coronary artery | UBERON:0001621 | 74.82 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 73.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 73.20 | gold quality |
| quadriceps femoris | UBERON:0001377 | 72.85 | gold quality |
| aorta | UBERON:0000947 | 71.87 | gold quality |
| triceps brachii | UBERON:0001509 | 71.10 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.04 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 70.95 | gold quality |
| gluteal muscle | UBERON:0002000 | 70.44 | gold quality |
| embryo | UBERON:0000922 | 69.69 | gold quality |
| secondary oocyte | CL:0000655 | 69.53 | gold quality |
| prefrontal cortex | UBERON:0000451 | 69.52 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 69.18 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 68.71 | gold quality |
| pancreatic ductal cell | CL:0002079 | 68.38 | silver quality |
| thymus | UBERON:0002370 | 67.81 | gold quality |
| thoracic aorta | UBERON:0001515 | 67.08 | gold quality |
| ascending aorta | UBERON:0001496 | 66.53 | gold quality |
| cervix epithelium | UBERON:0004801 | 66.41 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 65.93 | gold quality |
| endothelial cell | CL:0000115 | 65.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.67 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- GPR21 is up-regulated in type 2 diabetes. (PMID:27243589)
- Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms. (PMID:34782333)
- G protein-coupled receptor 21 in macrophages: An in vitro study. (PMID:35537492)
- Cryo-EM structures of orphan GPR21 signaling complexes. (PMID:36639690)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gpr21 | ENSMUSG00000053164 |
| rattus_norvegicus | Gpr21 | ENSRNOG00000078766 |
Paralogs (25): DRD4 (ENSG00000069696), HRH3 (ENSG00000101180), HRH2 (ENSG00000113749), CHRM3 (ENSG00000133019), HRH4 (ENSG00000134489), TAAR5 (ENSG00000135569), GPR84 (ENSG00000139572), GPR161 (ENSG00000143147), TAAR2 (ENSG00000146378), TAAR6 (ENSG00000146383), TAAR8 (ENSG00000146385), TAAR1 (ENSG00000146399), DRD3 (ENSG00000151577), HTR4 (ENSG00000164270), CHRM1 (ENSG00000168539), DRD5 (ENSG00000169676), HTR1A (ENSG00000178394), HTR1D (ENSG00000179546), CHRM4 (ENSG00000180720), CHRM2 (ENSG00000181072), DRD1 (ENSG00000184845), CHRM5 (ENSG00000184984), HRH1 (ENSG00000196639), GPR52 (ENSG00000203737), TAAR9 (ENSG00000237110)
Protein
Protein identifiers
Probable G-protein coupled receptor 21 — Q99679 (reviewed: Q99679)
All UniProt accessions (2): Q99679, H9NIL4
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor.
Subcellular location. Cell membrane.
Tissue specificity. Not detected in the brain regions thalamus, putamen, caudate, frontal cortex, pons, hypothalamus, hippocampus.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_005285* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR050569 | TAAR | Family |
Pfam: PF00001
UniProt features (34 total): helix 12, topological domain 8, transmembrane region 7, glycosylation site 2, strand 2, turn 2, chain 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8HMV | ELECTRON MICROSCOPY | 2.91 |
| 8HIX | ELECTRON MICROSCOPY | 3.12 |
| 8HJ0 | ELECTRON MICROSCOPY | 3.12 |
| 8HJ1 | ELECTRON MICROSCOPY | 3.27 |
| 8HJ2 | ELECTRON MICROSCOPY | 3.8 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99679-F1 | 83.75 | 0.54 |
Antibody-complex structures (SAbDab): 5 — 8HIX, 8HJ0, 8HJ1, 8HJ2, 8HMV
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 2, 8
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 80 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, RRAGTTGT_UNKNOWN, GOBP_RESPONSE_TO_NITROGEN_COMPOUND, MULLIGHAN_NPM1_SIGNATURE_3_UP, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, CMYB_01, GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS, GOBP_GROWTH, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, CAGCTG_AP4_Q5, GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_RESPONSE_TO_INSULIN
GO Biological Process (6): G protein-coupled receptor signaling pathway (GO:0007186), insulin receptor signaling pathway (GO:0008286), positive regulation of multicellular organism growth (GO:0040018), glucose homeostasis (GO:0042593), negative regulation of insulin receptor signaling pathway (GO:0046627), signal transduction (GO:0007165)
GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| cell surface receptor protein tyrosine kinase signaling pathway | 1 |
| cellular response to insulin stimulus | 1 |
| multicellular organism growth | 1 |
| regulation of multicellular organism growth | 1 |
| positive regulation of developmental growth | 1 |
| positive regulation of multicellular organismal process | 1 |
| carbohydrate homeostasis | 1 |
| insulin receptor signaling pathway | 1 |
| negative regulation of signal transduction | 1 |
| regulation of insulin receptor signaling pathway | 1 |
| negative regulation of cellular response to insulin stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
317 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR21 | GPR20 | Q99678 | 938 |
| GPR21 | RC3H2 | Q9HBD1 | 527 |
| GPR21 | STRBP | Q96SI9 | 431 |
| GPR21 | RABGAP1 | Q9Y3P9 | 403 |
| GPR21 | GPR12 | P47775 | 390 |
| GPR21 | TMEM71 | Q6P5X7 | 374 |
| GPR21 | CRB2 | Q5IJ48 | 358 |
| GPR21 | RGR | P47804 | 341 |
| GPR21 | GOLGA1 | Q92805 | 331 |
| GPR21 | SGK2 | Q9HBY8 | 320 |
| GPR21 | GNA14 | O95837 | 291 |
| GPR21 | AASS | Q9UDR5 | 290 |
| GPR21 | GNA15 | P30679 | 269 |
| GPR21 | IMPG1 | Q17R60 | 257 |
| GPR21 | TANC1 | Q9C0D5 | 256 |
| GPR21 | ALG3 | Q92685 | 256 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPR21 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| RAMP1 | GPR21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR21 | RAMP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR21 | RAMP2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP2 | GPR21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RAMP3 | GPR21 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR21 | RAMP3 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GPR21 | ATP13A2 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (144): MARCH6 (Affinity Capture-MS), ERMP1 (Affinity Capture-MS), OTUD6A (Affinity Capture-MS), S1PR5 (Affinity Capture-MS), FZD3 (Affinity Capture-MS), SIDT2 (Affinity Capture-MS), ZDHHC5 (Affinity Capture-MS), SLC6A6 (Affinity Capture-MS), SLC15A4 (Affinity Capture-MS), SLC47A1 (Affinity Capture-MS), ADCY9 (Affinity Capture-MS), FZD2 (Affinity Capture-MS), EDA (Affinity Capture-MS), CNNM1 (Affinity Capture-MS), VEZT (Affinity Capture-MS)
ESM2 similar proteins: A0A678XMK4, A6QLE7, G3M4F8, O08890, O42384, O42574, O70528, P07550, P0C5J4, P10608, P17124, P18762, P25021, P25102, P28221, P28222, P28334, P28564, P28565, P28566, P30939, P30940, P35404, P35406, P46636, P47747, P56496, P60020, P60021, P61752, P79748, P97288, Q02284, Q0EAB5, Q13639, Q28044, Q28509, Q588Y6, Q61224, Q62758
Diamond homologs: A0T2N3, A6QLE7, O02213, O15973, O19091, O46635, O60755, O77621, O77721, P08908, P08909, P0C5J4, P11613, P14842, P18599, P19327, P22270, P25102, P28223, P28286, P34968, P35363, P41595, P46093, P50128, P50129, P50132, P56481, P79960, Q0EAB6, Q1JQB3, Q25321, Q25322, Q2TAD5, Q4KLH9, Q4LBB6, Q4VA82, Q5IS66, Q5R4Q6, Q60F97
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
344 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:123035068:T:A | acceptor_gain | 0.9100 |
| 9:123035066:ACTGG:A | acceptor_gain | 0.8700 |
| 9:123035069:G:A | acceptor_gain | 0.8700 |
| 9:123035066:ACTG:A | acceptor_gain | 0.8600 |
| 9:123034992:ACCCT:A | acceptor_gain | 0.8300 |
| 9:123035066:ACT:A | acceptor_gain | 0.8300 |
| 9:123034170:GCT:G | acceptor_gain | 0.8100 |
| 9:123034657:G:GT | donor_gain | 0.8000 |
| 9:123034252:ACTT:A | acceptor_gain | 0.7900 |
| 9:123034255:T:A | acceptor_gain | 0.7600 |
| 9:123034247:C:G | acceptor_gain | 0.7400 |
| 9:123034589:A:AG | donor_gain | 0.7300 |
| 9:123034993:C:G | acceptor_gain | 0.7300 |
| 9:123034246:A:AG | acceptor_gain | 0.6400 |
| 9:123035359:T:TA | acceptor_gain | 0.6400 |
| 9:123035203:A:AG | acceptor_gain | 0.6200 |
| 9:123034992:A:AG | acceptor_gain | 0.6100 |
| 9:123035066:A:AG | acceptor_gain | 0.6100 |
| 9:123035207:T:G | acceptor_gain | 0.6100 |
| 9:123035042:T:TA | acceptor_gain | 0.6000 |
| 9:123035206:A:AG | acceptor_gain | 0.5800 |
| 9:123034166:A:T | acceptor_gain | 0.5700 |
| 9:123034378:G:GT | donor_gain | 0.5700 |
| 9:123034169:A:AG | acceptor_gain | 0.5600 |
| 9:123034170:G:GG | acceptor_gain | 0.5600 |
| 9:123034727:ACTGT:A | acceptor_gain | 0.5600 |
| 9:123034728:C:G | acceptor_gain | 0.5500 |
| 9:123034996:T:TA | acceptor_gain | 0.5500 |
| 9:123035103:GTGGT:G | acceptor_gain | 0.5500 |
| 9:123035387:T:A | acceptor_gain | 0.5400 |
AlphaMissense
2315 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:123034936:A:C | S124R | 0.999 |
| 9:123034938:C:A | S124R | 0.999 |
| 9:123034938:C:G | S124R | 0.999 |
| 9:123035026:T:A | W154R | 0.999 |
| 9:123035026:T:C | W154R | 0.999 |
| 9:123035347:T:C | F261L | 0.999 |
| 9:123035349:T:A | F261L | 0.999 |
| 9:123035349:T:G | F261L | 0.999 |
| 9:123034704:C:A | N46K | 0.998 |
| 9:123034704:C:G | N46K | 0.998 |
| 9:123034789:G:C | D75H | 0.998 |
| 9:123034790:A:C | D75A | 0.998 |
| 9:123034790:A:G | D75G | 0.998 |
| 9:123034790:A:T | D75V | 0.998 |
| 9:123034791:C:A | D75E | 0.998 |
| 9:123034791:C:G | D75E | 0.998 |
| 9:123034801:G:A | G79R | 0.998 |
| 9:123034801:G:C | G79R | 0.998 |
| 9:123034801:G:T | G79W | 0.998 |
| 9:123034802:G:A | G79E | 0.998 |
| 9:123035359:T:A | W265R | 0.998 |
| 9:123035359:T:C | W265R | 0.998 |
| 9:123035366:C:A | P267Q | 0.998 |
| 9:123035366:C:G | P267R | 0.998 |
| 9:123035449:A:C | S295R | 0.998 |
| 9:123035451:T:A | S295R | 0.998 |
| 9:123035451:T:G | S295R | 0.998 |
| 9:123035454:C:A | N296K | 0.998 |
| 9:123035454:C:G | N296K | 0.998 |
| 9:123035455:A:C | S297R | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000024059 (9:123036317 G>A), RS1000054792 (9:123036678 A>G), RS1000190344 (9:123047171 T>C,G), RS1000282955 (9:123043895 A>C,G,T), RS1000327249 (9:123049569 T>C,G), RS1000665010 (9:123048135 C>G,T), RS1000888901 (9:123035977 TAA>T), RS1001489086 (9:123032798 A>G), RS1001521616 (9:123033185 G>C), RS1001641883 (9:123032868 G>A,C,T), RS1002046539 (9:123039668 G>A), RS1002211032 (9:123045315 A>G), RS1002491966 (9:123034472 A>G,T), RS1002846223 (9:123047786 G>A), RS1002877323 (9:123047964 G>T)
Disease associations
OMIM: gene MIM:601909 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_64 | Body mass index | 2.000000e-10 |
| GCST008362_190 | Birth weight | 6.000000e-16 |
| GCST009616_3 | HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction | 7.000000e-07 |
| GCST010703_296 | Brain morphology (MOSTest) | 2.000000e-14 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004344 | birth weight |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523913 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with only surrogate ligands
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| cinnamaldehyde | increases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| epigallocatechin gallate | increases expression, affects cotreatment | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Sunitinib | increases expression | 1 |
| Cadmium | decreases expression | 1 |
| T-2 Toxin | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Vanadates | decreases expression | 1 |
| Lactic Acid | affects expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883439 | Binding | PRESTO-Tango GPCRome screening (GPR21) | Data for DCP probe UCSF924 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.